News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Key Takeaways in the Treatment of Advanced Colorectal Cancer

EP. 1: Key Takeaway 1: Adjuvant Therapy Optimal Duration

September 16th 2019

EP. 2: Key Takeaway 2: Frontline Neoadjuvant Chemotherapy

September 16th 2019

EP. 3: Key Takeaway 3: Determining Tumor Mutational Status

September 16th 2019

EP. 4: Key Takeaway 4: Right-Sided Tumors: Anti-Angiogenic Treatment

September 16th 2019

EP. 5: Key Takeaway 5: Dosing of Multiple Kinase Inhibitors

September 16th 2019

EP. 6: Key Takeaway 6: I/O: Combination vs Monotherapy

September 16th 2019

EP. 7: Key Takeaway 7: Role of Immunotherapy in MSI-High MCRC

September 16th 2019

EP. 8: Key Takeaway 8: MSI-High Status and HER2 Amplification

September 16th 2019

Trending on OncLive

FDA Approves Bioequivalent Olaparib Across Previously Approved Cancer Indications

Longer-Term Data Help Shape TKI Selection in ROS1+ and ALK+ NSCLC

Experts Revisit the Most Notable Data in GU Oncology From ASCO 2026

Dr Mardones on Giredestrant Plus Palbociclib in Estrogen Receptor+ Breast Cancer

Sacituzumab Govitecan Yields Responses in Platinum-Resistant Ovarian Cancer